RxDoctor Payments Data

Gerald Berry, MD

Anatomic Pathology & Clinical Pathology · Stanford, CANPI 1770678427

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,250 of the $49,020 with a category attached, or 78.0%. Every reported general payment came from a single manufacturer, Merck. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,020in general payments, 2019–2025

Across 40 payments — averaging $1225.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$49K

What the payments were for

  • Consulting fees$3,0006%
  • Speaking & faculty fees$38,25078%
  • Travel & lodging$7,25215%
  • Food & beverage$5181%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck40$49,020

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,020 in reported general payments places this provider in the 90th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Medicare billing

Part B allowed, 2024
$328,202
Medicare patients
1,970
Services billed
7,863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →